Recently, an important study titled “Stenting for Malignant Central Airway Obstruction in 100 Cases: Short- and Long-Term Outcomes and Lessons Learned” was accepted for an oral presentation at the 49th Annual Meeting of the Society of Thoracic Surgeons (STS) 2013. The purpose of the study was to evaluate the survival of patients undergoing airway-stenting for malignant central airway obstruction. At Mount Sinai St.Luke’s-Roosevelt Hospital, Dr. Faiz Bhora and his team including Dr. Robert Lebovics and Dr. Andrew Evans have performed more than 500 airway procedures, both for malignant and benign airway obstruction, many combined with radiation therapy. They were the first to demonstrate that timely stenting, especially when performed before the worsening of performance status, leads to additional survival benefit.
This research was carried out by the members of the Thoracic Surgery Research Lab. The lab is directed by Dr. Faiz Bhora and consists of 4 research fellows: Jordan Sasson, Sadiq Rehmani, Sarah Almubarak and Hassan Sheikh. Sadiq Rehmani was the lead person on this project. The broader interests of the lab include identification of genetic markers in response to radiation therapy in lung cancers, performing innovative robotic procedures and airway bioengineering. The lab is also interested in carrying out various quality improvement and outcomes research related to thoracic and general surgery.